Table 2. Outcomes among patients based on anticoagulation use.
Outcome | Warfarin (n = 160177) | Dabigatran (n = 14968) | Rivaroxaban (n = 11877) | Apixaban (n = 9495) |
Ischemic stroke | 21619 (13.5%) | 1663 (11.1%) | 1427 (12.0%) | 1331 (14.0%) |
Hemorrhagic stroke | 1875 (1.2%) | 88 (0.6%) | 88 (0.7%) | 79 (0.8%) |
Data are presented as n (%).